- Home
- PRPO vs HKPD Comparison
PRPO vs HKPD Comparison
Compare PRPO & HKPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPO
- HKPD
- Stock Information
- Founded
- PRPO N/A
- HKPD 2016
- Country
- PRPO United States
- HKPD Hong Kong
- Employees
- PRPO N/A
- HKPD N/A
- Industry
- PRPO Biotechnology: Laboratory Analytical Instruments
- HKPD Other Pharmaceuticals
- Sector
- PRPO Industrials
- HKPD Health Care
- Exchange
- PRPO Nasdaq
- HKPD Nasdaq
- Market Cap
- PRPO 22.0M
- HKPD 20.9M
- IPO Year
- PRPO N/A
- HKPD 2025
- Fundamental
- Price
- PRPO $15.41
- HKPD $1.14
- Analyst Decision
- PRPO
- HKPD
- Analyst Count
- PRPO 0
- HKPD 0
- Target Price
- PRPO N/A
- HKPD N/A
- AVG Volume (30 Days)
- PRPO 10.3K
- HKPD 7.9M
- Earning Date
- PRPO 08-13-2025
- HKPD 01-01-0001
- Dividend Yield
- PRPO N/A
- HKPD N/A
- EPS Growth
- PRPO N/A
- HKPD N/A
- EPS
- PRPO N/A
- HKPD N/A
- Revenue
- PRPO $21,242,000.00
- HKPD $20,313,818.00
- Revenue This Year
- PRPO N/A
- HKPD N/A
- Revenue Next Year
- PRPO N/A
- HKPD N/A
- P/E Ratio
- PRPO N/A
- HKPD N/A
- Revenue Growth
- PRPO 27.05
- HKPD 21.72
- 52 Week Low
- PRPO $3.90
- HKPD $0.81
- 52 Week High
- PRPO $16.89
- HKPD $3.79
- Technical
- Relative Strength Index (RSI)
- PRPO 69.89
- HKPD 58.19
- Support Level
- PRPO $14.04
- HKPD $0.96
- Resistance Level
- PRPO $16.27
- HKPD $1.76
- Average True Range (ATR)
- PRPO 0.64
- HKPD 0.21
- MACD
- PRPO 0.10
- HKPD 0.05
- Stochastic Oscillator
- PRPO 84.48
- HKPD 27.16
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
About HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.